Artificial Intelligence in Pharmacovigilance: Eight Action Items for Life Sciences Companies
... risk management , transparency, human oversight, and data protection. Whether an AI system in PV is “high- risk ” depends on its specific use and may ...
Read the original at Key Areas of Impact for Life Sciences Companies ↗
- Topics
- Governance & Risk ManagementHealthcare
- Tracked via
- “AI Risk Managment”